期刊文献+

肿瘤患者化疗期间的生活质量调查与分析 被引量:35

Investigation of cancer patients' quality of life during chemotherapy
下载PDF
导出
摘要 目的:探讨肺癌、乳腺癌及消化道恶性肿瘤患者化疗期间的生活质量状况及其影响因素。方法:选用生活质量问卷(QLQ-C30,QLQ-LC13,QLQ-BR21)对267名化疗患者进行调查,统计学方法采用t检验及多因素相关分析。结果:肺癌和消化道肿瘤患者生活质量在化疗前、化疗早期及后期组间未见统计学差异;乳腺癌患者化疗后较化疗前在疲乏(P=0.010)、失眠(P=0.007)、恶心呕吐(P=0.0001)及厌食(P=0.016)方面呈加重趋势,认知功能也在一定程度上受到损害(P=0.020)。生活质量影响因素之间的交互作用明显,经济因素明显影响肿瘤患者的生活质量。结论:乳腺癌患者化疗期间疲乏、失眠及消化道症状呈加重趋势,经济因素对癌症患者生活质量的影响不容忽视。 Objective: To assess the quality of life (QOL) and influential factors in lung, breast and intestinal tract cancer patients during chemotherapy. Methods: QOL Questionnaires ( QLQ - C30, QLQ - LC13, QLQ - BP,21 ) were used as main instruments of QOL in 267 patients during chemotherapy. Results: QOL showed no significant difference among pre - chemotherapy, early and late period of during chemotherapy in lung cancer patients and intestinal tract cancer patients. The symptoms of fatigue ( P = 0. 0096 ) , insomnia ( P = 0. 0067 ) , appetite loss( P = 0.0156), nausea and vomiting (P = 0.0001 )were worse in breast cancer patients, as well as cognitive function ( P = 0. 0198 ). Many factors influenced the QOL by the form of interaction. Conclusion : Most indexes of QOL showed no significant difference except fatigue, insomnia and intestinal symptoms in breast cancer patients. Economic status played an important role in the quality of life of cancer patients.
出处 《现代肿瘤医学》 CAS 2007年第6期860-862,共3页 Journal of Modern Oncology
关键词 生活质量 调查 癌症患者 影响因素 quality of Life investigation cancer patients influential factors
  • 相关文献

参考文献7

  • 1Sprangers MA,Groenvold M,Arraras JI,et al.The European Organization for Research and Treatment of Cancer breast cancerspecific quality-of-life questionnaire module:first results from a three-country field study[J].J Clin Oncol,1996,14(10):2756~2768.
  • 2孟琼,万崇华,罗家洪.癌症患者生命质量测定量表EORT CQLQ-C30的应用[J].中国行为医学科学,2005,14(3):273-274. 被引量:146
  • 3Effieace F,Bottomley A,Vanvoorden V,et al.Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials[J].Eur J Cancer,2004,40(2):187~197.
  • 4Bottomley A,Gaafar R,Manegold C,et al.Short-term treatment -related symptoms and quality of life:resultsfrom an international randomized phase Ⅲ study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma:an EORTC LungCancer Group and National Cancer Institute,Canada,Intergroup Study[J].J Clin Oncol,2006,24(9):1435~1442.
  • 5王建平,崔俊南,陈仲庚,林文娟,罗键,孙燕.癌症患者生活质量状况及影响因素研究[J].中国临床心理学杂志,2000,8(1):23-26. 被引量:104
  • 6Brandberg Y,Michelson H,Nilsson B,et al.Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide,thiotepa,and carboplatin or tailored therapy with Fluorouracil,epirubicin,and cyclophosphamide:Scandinavian Breast Group Study 9401[J].J Clin Oncol,2003,21(19):3659~3664.
  • 7Bottomley A,Therasse P,Piccart M,et al.Health-related quality of life in survivors of locally advanced breast cancer:an intemational randomised controlled phase Ⅲ trial[J].Lancet Oncol,2005.6:287~294.

二级参考文献21

  • 1Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30 : a quality of life instrument for use in international clinical trials in oncology. J Nail Cancer Inst, 1993,85 : 365-376.
  • 2Aaronson NK, Cull A, Kaasa S, et al. The EORTC modular approach to quality of life assessment in oncology. Int J Ment Health, 1994,23:75-96.
  • 3Webb A, Cunningham D, Scarffe JH, et al. Randomized trial comparing epirubicin, cisplatin and fluoroumcil versus fluorouracil, doxorubicin znd methotrexate in advanced esophago gastric cancer . J Clin Oncol, 1997, 15:261-267.
  • 4Chie WC, Chang KJ, Huang CS, Kuo WH. Quality of life of breast cancer patients in Taiwan validation of the Taiwan Chinese version of the QLQ-C30 and EORTC QLQ-BR23. Psychooncology, 2003, 12 ( 7 ) :729-735.
  • 5Bamias A, Hill ME, Cunningham D, et al. Epia-ubicin, cisplatin, and protracted venous infusion of 5-fluorouacil for esophagogastic ademocacinoma: response. Toxicity Quality of life And survival . Cancer, 1996,77 : 1978.
  • 6Gilmelius B, Ekstrom K, Hoffman K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol, 1997, 8: 163.
  • 7Luman W, Cull A, Palmer KR. Quality of life in patients stetted for malignant biliary obstructions. Eur J Gastroenterol Hepatol, 1997,9:481.
  • 8Miyanaga N, Akaza H, Shinohara N, et al. Assessment of QOL and survival for patients undergoing radical cystectomy or bladder preservation for invasive bladder cancer . Nippon Hinyokika Gakkai Zasshi,1999, 54(2) : 109-115.
  • 9Brandberg Y, Michelson H, Nisson B, et al. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epimbicin, and cyclophosphamide : Scandimavian Breast Group Study. J Clin Oncol, 2003, 21 (19) : 3659-3664.
  • 10Witzigmann H. Quality of life in chronic pancreatitis : A prospective trial comparing classical whipple procedure and dudenum-preserving pancreatitis head resection. Journal of Gastrointestinal Surgery, 2002,6 ( 2 ) :173-179.

共引文献247

同被引文献280

引证文献35

二级引证文献309

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部